Hormones in pregnancy
暂无分享,去创建一个
[1] A. Csapo,et al. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. , 1973, American journal of obstetrics and gynecology.
[2] J. Honour,et al. The timing of placental competence in pregnancy after oocyte donation. , 1993, Fertility and sterility.
[3] L. Regan,et al. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. , 1997, Human reproduction.
[4] S. Fisher,et al. Human Placental Cytotrophoblasts Attract Monocytes and Cd56bright Natural Killer Cells via the Actions of Monocyte Inflammatory Protein 1α , 2001, The Journal of experimental medicine.
[5] J. Zittoun,et al. Low Vitamin B(12) level as a risk factor for very early recurrent abortion. , 2002, European journal of obstetrics, gynecology, and reproductive biology.
[6] B. Sibai,et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate , 2003 .
[7] S. Daya,et al. WITHDRAWN: Luteal phase support in assisted reproduction cycles. , 2008, The Cochrane database of systematic reviews.
[8] E. Capp,et al. Pharmacokinetics of Natural Progesterone Vaginal Suppository , 2004, Gynecologic and Obstetric Investigation.
[9] A. Mattei,et al. Progesterone and pregnancy , 2005, Current opinion in obstetrics & gynecology.
[10] B. Hurst,et al. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. , 2006, Fertility and sterility.
[11] A. Fayed,et al. Progestogen for treating threatened miscarriage. , 2018, The Cochrane database of systematic reviews.
[12] K. Walch,et al. Progesterone for recurrent miscarriage: truth and deceptions. , 2008, Best practice & research. Clinical obstetrics & gynaecology.
[13] S. Borna,et al. Progesterone for Maintenance Tocolytic Therapy After Threatened Preterm Labor: A Randomized Controlled Trial , 2008 .
[14] M. El-Zibdeh,et al. Dydrogesterone support in threatened miscarriage. , 2009, Maturitas.
[15] B. Sibai,et al. Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety , 2008, Therapeutics and clinical risk management.
[16] K. Poppe,et al. Thyroid function and human reproductive health. , 2010, Endocrine reviews.
[17] P. Middleton,et al. Interventions for clinical and subclinical hypothyroidism in pregnancy. , 2010, The Cochrane database of systematic reviews.
[18] T. Var,et al. Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomised study. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[19] M. Beckmann,et al. Thyroid hormone receptors and reproduction. , 2010, Journal of reproductive immunology.
[20] B. Stray-Pedersen,et al. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. , 2011, Journal of reproductive immunology.
[21] A. Barut,et al. Effect of Progesterone as a Tocolytic and in Maintenance Therapy during Preterm Labor , 2011, Gynecologic and Obstetric Investigation.
[22] E. Fliers,et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. , 2012, Human reproduction update.
[23] Shannon D. Sullivan,et al. Thyroid disorders during pregnancy. , 2014, Endocrinology and metabolism clinics of North America.